gdc-1971
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Aug 17, 2022 (NCT05487235)
Timeline
2020s
- Jan 1, 2022
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Protein-tyrosine phosphatase 2CINHIBITOR
PTPN11 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05954871 | Phase 1 | Dec 15, 2023 | Genentech, Roche |
| NCT05487235 | Phase 1 | Aug 17, 2022 | Genentech, Roche |
Showing 2 of 2 trials
Page 1 / 1